Cargando…

Which Classification of Cavernous Sinus Syndrome is Better - Ishikawa or Jefferson? A Prospective Study of 73 Patients

INTRODUCTION: Ishikawa and Jefferson are the two most commonly used systems used for the classification of cavernous sinus syndrome (CSS). However, relative utilities of these two classification systems have not been evaluated in detail in developing countries. In this study, we compared relative ut...

Descripción completa

Detalles Bibliográficos
Autores principales: Bhatkar, Sanat, Goyal, Manoj Kumar, Takkar, Aastha, Modi, Manish, Mukherjee, Kanchan K., Singh, Paramjeet, Radotra, Bishan Das, Singh, Ramandeep, Lal, Vivek
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5244064/
https://www.ncbi.nlm.nih.gov/pubmed/28163507
http://dx.doi.org/10.4103/0976-3147.196448
_version_ 1782496631701110784
author Bhatkar, Sanat
Goyal, Manoj Kumar
Takkar, Aastha
Modi, Manish
Mukherjee, Kanchan K.
Singh, Paramjeet
Radotra, Bishan Das
Singh, Ramandeep
Lal, Vivek
author_facet Bhatkar, Sanat
Goyal, Manoj Kumar
Takkar, Aastha
Modi, Manish
Mukherjee, Kanchan K.
Singh, Paramjeet
Radotra, Bishan Das
Singh, Ramandeep
Lal, Vivek
author_sort Bhatkar, Sanat
collection PubMed
description INTRODUCTION: Ishikawa and Jefferson are the two most commonly used systems used for the classification of cavernous sinus syndrome (CSS). However, relative utilities of these two classification systems have not been evaluated in detail in developing countries. In this study, we compared relative utilities of these two classification schemes in the evaluation of CSS. OBJECTIVE: To compare the utility of Jefferson and Ishikawa classifications in the evaluation of CSS. PATIENTS AND METHODS: A total of 73 consecutive patients of CSS were prospectively classified using either Ishikawa or Jefferson classification and relative utility of these two classification schemes in determining etiology of CSS was compared. RESULTS: While only 46.6% of patients could be classified using Jefferson classification, 95.5% of patients could be classified using Ishikawa scheme. CSS was classified as anterior, middle, and posterior in 17.8%, 21.9%, and 8.2% of patients, respectively, as per the Jefferson classification. As per the Ishikawa classification, 37% of patients each showed anterior and posterior CSS, 16.4% showed middle CSS, whereas 4.1% had whole CSS. Middle CSS was significantly associated with the presence of fungal infections (P = 0.045) as per Jefferson classifications, and anterior CSS was significantly associated with a vascular etiology (P = 0.005) as per Ishikawa classification. Overall, inflammatory causes were the most common cause for anterior CSS, while tumors accounted for maximum cases of posterior CSS. CONCLUSION: Although more number of patients could be classified using Ishikawa classification, there was no advantage of Ishikawa classification over Jefferson with regard to determination of etiology of CSS.
format Online
Article
Text
id pubmed-5244064
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Medknow Publications & Media Pvt Ltd
record_format MEDLINE/PubMed
spelling pubmed-52440642017-02-03 Which Classification of Cavernous Sinus Syndrome is Better - Ishikawa or Jefferson? A Prospective Study of 73 Patients Bhatkar, Sanat Goyal, Manoj Kumar Takkar, Aastha Modi, Manish Mukherjee, Kanchan K. Singh, Paramjeet Radotra, Bishan Das Singh, Ramandeep Lal, Vivek J Neurosci Rural Pract Original Article INTRODUCTION: Ishikawa and Jefferson are the two most commonly used systems used for the classification of cavernous sinus syndrome (CSS). However, relative utilities of these two classification systems have not been evaluated in detail in developing countries. In this study, we compared relative utilities of these two classification schemes in the evaluation of CSS. OBJECTIVE: To compare the utility of Jefferson and Ishikawa classifications in the evaluation of CSS. PATIENTS AND METHODS: A total of 73 consecutive patients of CSS were prospectively classified using either Ishikawa or Jefferson classification and relative utility of these two classification schemes in determining etiology of CSS was compared. RESULTS: While only 46.6% of patients could be classified using Jefferson classification, 95.5% of patients could be classified using Ishikawa scheme. CSS was classified as anterior, middle, and posterior in 17.8%, 21.9%, and 8.2% of patients, respectively, as per the Jefferson classification. As per the Ishikawa classification, 37% of patients each showed anterior and posterior CSS, 16.4% showed middle CSS, whereas 4.1% had whole CSS. Middle CSS was significantly associated with the presence of fungal infections (P = 0.045) as per Jefferson classifications, and anterior CSS was significantly associated with a vascular etiology (P = 0.005) as per Ishikawa classification. Overall, inflammatory causes were the most common cause for anterior CSS, while tumors accounted for maximum cases of posterior CSS. CONCLUSION: Although more number of patients could be classified using Ishikawa classification, there was no advantage of Ishikawa classification over Jefferson with regard to determination of etiology of CSS. Medknow Publications & Media Pvt Ltd 2016-12 /pmc/articles/PMC5244064/ /pubmed/28163507 http://dx.doi.org/10.4103/0976-3147.196448 Text en Copyright: © Journal of Neurosciences in Rural Practice http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms.
spellingShingle Original Article
Bhatkar, Sanat
Goyal, Manoj Kumar
Takkar, Aastha
Modi, Manish
Mukherjee, Kanchan K.
Singh, Paramjeet
Radotra, Bishan Das
Singh, Ramandeep
Lal, Vivek
Which Classification of Cavernous Sinus Syndrome is Better - Ishikawa or Jefferson? A Prospective Study of 73 Patients
title Which Classification of Cavernous Sinus Syndrome is Better - Ishikawa or Jefferson? A Prospective Study of 73 Patients
title_full Which Classification of Cavernous Sinus Syndrome is Better - Ishikawa or Jefferson? A Prospective Study of 73 Patients
title_fullStr Which Classification of Cavernous Sinus Syndrome is Better - Ishikawa or Jefferson? A Prospective Study of 73 Patients
title_full_unstemmed Which Classification of Cavernous Sinus Syndrome is Better - Ishikawa or Jefferson? A Prospective Study of 73 Patients
title_short Which Classification of Cavernous Sinus Syndrome is Better - Ishikawa or Jefferson? A Prospective Study of 73 Patients
title_sort which classification of cavernous sinus syndrome is better - ishikawa or jefferson? a prospective study of 73 patients
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5244064/
https://www.ncbi.nlm.nih.gov/pubmed/28163507
http://dx.doi.org/10.4103/0976-3147.196448
work_keys_str_mv AT bhatkarsanat whichclassificationofcavernoussinussyndromeisbetterishikawaorjeffersonaprospectivestudyof73patients
AT goyalmanojkumar whichclassificationofcavernoussinussyndromeisbetterishikawaorjeffersonaprospectivestudyof73patients
AT takkaraastha whichclassificationofcavernoussinussyndromeisbetterishikawaorjeffersonaprospectivestudyof73patients
AT modimanish whichclassificationofcavernoussinussyndromeisbetterishikawaorjeffersonaprospectivestudyof73patients
AT mukherjeekanchank whichclassificationofcavernoussinussyndromeisbetterishikawaorjeffersonaprospectivestudyof73patients
AT singhparamjeet whichclassificationofcavernoussinussyndromeisbetterishikawaorjeffersonaprospectivestudyof73patients
AT radotrabishandas whichclassificationofcavernoussinussyndromeisbetterishikawaorjeffersonaprospectivestudyof73patients
AT singhramandeep whichclassificationofcavernoussinussyndromeisbetterishikawaorjeffersonaprospectivestudyof73patients
AT lalvivek whichclassificationofcavernoussinussyndromeisbetterishikawaorjeffersonaprospectivestudyof73patients